ad-hoc-news

Comirnaty COVID-19 Impfstoff von BioNTech Pfizer - Indikation und zugelassene Varianten

Comirnaty COVID-19 mRNA Impfstoff ist in der EU zur aktiven Immunisierung gegen COVID-19 bei Personen ab 6 Monaten zugelassen und liegt in unterschiedlichen Varianten wie Konzentrat zur Herstellung ...
ad-hoc-news

Comirnaty 30 Mikrogramm/ Dosis von BioNTech Manufacturing GmbH - mRNA COVID-19 Impfstoff für Personen ab 12 Jahren

Comirnaty 30 Mikrogramm/Dosis ist ein COVID-19 mRNA Impfstoff mit dem Wirkstoff Tozinameran zur aktiven Immunisierung von Personen ab 12 Jahren gegen COVID-19. Für Jugendliche und Erwachsene spielt ...
Nasdaq

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Business Wire

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY ®

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of ...
Seeking Alpha

BioNTech: Reiterating Strong Buy Based On COMIRNATY Variant Expansion And More

The last time I spoke about BioNTech SE (BNTX), it was with a Seeking Alpha article entitled "BioNTech: Maintaining “Strong Buy” After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart." With respect ...
Yahoo Finance

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...